Judicial reorganisation and a €342.9M impairment led to a €366.1M net loss for FY 2025-2026, despite stable gross margins and a 4.1% sales increase in Q1 2026-2027. Strategic focus is on cost reduction, selective investment, and leveraging strong IPs.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.